PRESS RELEASE published on 06/22/2023 at 22:05, 1 year 5 months ago Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/05/2023 at 14:00, 1 year 5 months ago Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma
PRESS RELEASE published on 06/01/2023 at 22:05, 1 year 5 months ago Moderna to Present at Upcoming Conferences in June 2023
PRESS RELEASE published on 05/30/2023 at 14:00, 1 year 5 months ago Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
PRESS RELEASE published on 05/19/2023 at 13:00, 1 year 6 months ago Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/04/2023 at 12:30, 1 year 6 months ago Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 05/03/2023 at 22:05, 1 year 6 months ago Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
PRESS RELEASE published on 05/02/2023 at 23:15, 1 year 6 months ago Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines
PRESS RELEASE published on 04/20/2023 at 22:05, 1 year 7 months ago Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
PRESS RELEASE published on 04/20/2023 at 13:30, 1 year 7 months ago Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
Published on 11/26/2024 at 01:00, 35 minutes ago FE Battery Metals Corp. Commences 2024 Winter Drilling Program
Published on 11/26/2024 at 00:37, 58 minutes ago CORRECTION; CoTec Holdings Corp. Announces Convertible Loan Agreement
Published on 11/26/2024 at 00:20, 1 hour 15 minutes ago NexgenRx Announces Third Quarter Results and Declaration of Divdend
Published on 11/26/2024 at 00:00, 1 hour 35 minutes ago Medicure Reports Financial Results For Quarter Ended September 30, 2024
Published on 11/26/2024 at 00:00, 1 hour 35 minutes ago Justera Health Revises Vesting Schedule of RSU Grant
Published on 11/25/2024 at 20:35, 5 hours ago Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing
Published on 11/25/2024 at 20:35, 5 hours ago World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 : Le Maroc se positionne comme leader des industries de nouvelle génération
Published on 11/25/2024 at 20:34, 5 hours 1 minute ago Avolta wins new ten-year contract, adds Manaus Airport to Brazil portfolio
Published on 11/25/2024 at 19:00, 6 hours 35 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 18 NOVEMBRE 2024 au 22 NOVEMBRE 2024
Published on 11/25/2024 at 18:55, 6 hours 40 minutes ago Molten Ventures Plc: HOL-Holding(s) in Company
Published on 11/25/2024 at 18:00, 7 hours 35 minutes ago Chiffre d’affaires consolidé 2023-2024 : 91 M€ en repli de 9,4 %
Published on 11/25/2024 at 17:55, 7 hours 40 minutes ago Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
Published on 11/25/2024 at 17:55, 7 hours 40 minutes ago Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 7 hours 50 minutes ago Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 7 hours 50 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 19 et le 22 novembre 2024
